# Corrigendum: LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2

**Authors:** Cheng Zhang, Tong Kang, Xinyi Wang, Jizhao Wang, Lin Liu, Jiawei Zhang, Xu Liu, Rong Li, Jiansheng Wang, Jia Zhang

PMC · DOI: 10.3389/fphar.2025.1424320 · 2025-03-14

## Full-text entities

- **Genes:** EZH2 (enhancer of zeste 2 polycomb repressive complex 2 subunit) [NCBI Gene 2146] {aka ENX-1, ENX1, EZH2b, KMT6, KMT6A, WVS}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, LINC-PINT (long intergenic non-protein coding RNA, p53 induced transcript) [NCBI Gene 378805] {aka LincRNA-Pint, MKLN1-AS1, PINT, PINT87aa, TISPL}
- **Diseases:** gastric cancer (MESH:D013274)
- **Chemicals:** cisplatin (MESH:D002945)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11951266/full.md

---
Source: https://tomesphere.com/paper/PMC11951266